Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency

Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis. In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the rpoB gene were sequenced from 131 randomly selected mutants...

Full description

Saved in:
Bibliographic Details
Published in:Annals of clinical microbiology and antimicrobials 2005-06, Vol.4 (1), p.9-9, Article 9
Main Authors: Anthony, Richard M, Schuitema, Anja R J, Bergval, Indra L, Brown, Tim J, Oskam, Linda, Klatser, Paul R
Format: Article
Language:English
Subjects:
Bacterial Proteins - genetics
Codon
DNA-Directed RNA Polymerases
Drug Resistance, Bacterial
Microbial Sensitivity Tests
Mutation
Mycobacterium tuberculosis
Mycobacterium tuberculosis - drug effects
Mycobacterium tuberculosis - genetics
Rifabutin - pharmacology
Rifampin - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b4819-4aecc794bd28bdf92ec1f80713b53d9662955fa2f4ab9ea75f669c2eb84454063
cites cdi_FETCH-LOGICAL-b4819-4aecc794bd28bdf92ec1f80713b53d9662955fa2f4ab9ea75f669c2eb84454063
container_end_page 9
container_issue 1
container_start_page 9
container_title Annals of clinical microbiology and antimicrobials
container_volume 4
creator Anthony, Richard M
Schuitema, Anja R J
Bergval, Indra L
Brown, Tim J
Oskam, Linda
Klatser, Paul R
description Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis. In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the rpoB gene were sequenced from 131 randomly selected mutants. Second round selection resulted in a changed frequency of specific mutations. Mycobacterium tuberculosis (strain Mtb72) rifamycin resistant mutants were selected in vitro with either rifampicin or rifabutin. One mutant R190 (rpoB S522L) selected with rifampicin had a rifampicin MIC of 32 microg/ml but remained sensitive to rifabutin (MIC10 times the frequency by the S522L mutant than the parent strain. First round selection of mutation S522L with rifampicin increased the frequency and changed the spectrum of mutations identified after selection with rifabutin.
doi_str_mv 10.1186/1476-0711-4-9
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6d29b73e492e4dd483d6ab220dea26c5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6d29b73e492e4dd483d6ab220dea26c5</doaj_id><sourcerecordid>19479629</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4819-4aecc794bd28bdf92ec1f80713b53d9662955fa2f4ab9ea75f669c2eb84454063</originalsourceid><addsrcrecordid>eNqFkktv1DAURiMEoqWwZIssFuwCduI48QZRVTwqFbGBteXHTfEosad-jDS_p38UZ2ZUZkCIlZPc4-PP96aqXhL8lpCBvSO0ZzXuCalpzR9V5w_vj4-ez6pnMa4wbjBm_dPqjHS8Gwjrz6v7S32XbbTJeof8iIIdpcrJOhQg2pik04DUFsldZV5bfVRKaM67pWz8utVeSZ0g2DyjlBUEnSdfQGTdxk8biEg6lF2OWU4orkGnUMiydZEs5y-AQTDBRiYwaAxwl8Hp7fPqySinCC8O60X149PH71df6ptvn6-vLm9qRQfCaypB655TZZpBmZE3oMk4lOu3qmsNZ6zhXTfKZqRScZB9NzLGdQNqoLSjmLUX1fXea7xciXWwswxb4aUVuw8-3AoZktUTCGYarvoWaDmFGkOH1jCpmgYbkA3TXXG937vWWc1gNLgU5HQiPa04-1Pc-o0oQx1w1xTBh71AWf8PwWlF-1ksAxfLwAUVvCjeHDIEXzoZk5ht1DBN0oHPUbChxOf8_yDhtOelfQV8_Qe48jm4MpTCcIZ7ipfk9R7SwccYYHwITfByPfZXzFfHrfpNH37S9hdk4O1W</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199607402</pqid></control><display><type>article</type><title>Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency</title><source>PubMed Central(OpenAccess)</source><creator>Anthony, Richard M ; Schuitema, Anja R J ; Bergval, Indra L ; Brown, Tim J ; Oskam, Linda ; Klatser, Paul R</creator><creatorcontrib>Anthony, Richard M ; Schuitema, Anja R J ; Bergval, Indra L ; Brown, Tim J ; Oskam, Linda ; Klatser, Paul R</creatorcontrib><description>Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis. In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the rpoB gene were sequenced from 131 randomly selected mutants. Second round selection resulted in a changed frequency of specific mutations. Mycobacterium tuberculosis (strain Mtb72) rifamycin resistant mutants were selected in vitro with either rifampicin or rifabutin. One mutant R190 (rpoB S522L) selected with rifampicin had a rifampicin MIC of 32 microg/ml but remained sensitive to rifabutin (MIC&lt;0.8 microg/ml). This mutant was subjected to a second round of selection with rifabutin. All 105 first round resistant mutants derived from the parent strain (Mtb72) screened acquired mutations within the 81 bp rpoB hotspot. When the rifampicin resistant but rifabutin sensitive S522L mutant was subjected to a second round of selection, single additional rpoB mutations were identified in 24 (92%) of 26 second round mutants studied, but 14 (54%) of these strains contained mutations outside the 81 bp hotspot (codons 144, 146, 148, 505). Additionally, spontaneous rifabutin resistant mutants were produced at &gt;10 times the frequency by the S522L mutant than the parent strain. First round selection of mutation S522L with rifampicin increased the frequency and changed the spectrum of mutations identified after selection with rifabutin.</description><identifier>ISSN: 1476-0711</identifier><identifier>EISSN: 1476-0711</identifier><identifier>DOI: 10.1186/1476-0711-4-9</identifier><identifier>PMID: 15958167</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Bacterial Proteins - genetics ; Codon ; DNA-Directed RNA Polymerases ; Drug Resistance, Bacterial ; Microbial Sensitivity Tests ; Mutation ; Mycobacterium tuberculosis ; Mycobacterium tuberculosis - drug effects ; Mycobacterium tuberculosis - genetics ; Rifabutin - pharmacology ; Rifampin - pharmacology</subject><ispartof>Annals of clinical microbiology and antimicrobials, 2005-06, Vol.4 (1), p.9-9, Article 9</ispartof><rights>2005 (c) Chiabrando et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</rights><rights>Copyright © 2005 Anthony et al; licensee BioMed Central Ltd. 2005 Anthony et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4819-4aecc794bd28bdf92ec1f80713b53d9662955fa2f4ab9ea75f669c2eb84454063</citedby><cites>FETCH-LOGICAL-b4819-4aecc794bd28bdf92ec1f80713b53d9662955fa2f4ab9ea75f669c2eb84454063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188052/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188052/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15958167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anthony, Richard M</creatorcontrib><creatorcontrib>Schuitema, Anja R J</creatorcontrib><creatorcontrib>Bergval, Indra L</creatorcontrib><creatorcontrib>Brown, Tim J</creatorcontrib><creatorcontrib>Oskam, Linda</creatorcontrib><creatorcontrib>Klatser, Paul R</creatorcontrib><title>Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency</title><title>Annals of clinical microbiology and antimicrobials</title><addtitle>Ann Clin Microbiol Antimicrob</addtitle><description>Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis. In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the rpoB gene were sequenced from 131 randomly selected mutants. Second round selection resulted in a changed frequency of specific mutations. Mycobacterium tuberculosis (strain Mtb72) rifamycin resistant mutants were selected in vitro with either rifampicin or rifabutin. One mutant R190 (rpoB S522L) selected with rifampicin had a rifampicin MIC of 32 microg/ml but remained sensitive to rifabutin (MIC&lt;0.8 microg/ml). This mutant was subjected to a second round of selection with rifabutin. All 105 first round resistant mutants derived from the parent strain (Mtb72) screened acquired mutations within the 81 bp rpoB hotspot. When the rifampicin resistant but rifabutin sensitive S522L mutant was subjected to a second round of selection, single additional rpoB mutations were identified in 24 (92%) of 26 second round mutants studied, but 14 (54%) of these strains contained mutations outside the 81 bp hotspot (codons 144, 146, 148, 505). Additionally, spontaneous rifabutin resistant mutants were produced at &gt;10 times the frequency by the S522L mutant than the parent strain. First round selection of mutation S522L with rifampicin increased the frequency and changed the spectrum of mutations identified after selection with rifabutin.</description><subject>Bacterial Proteins - genetics</subject><subject>Codon</subject><subject>DNA-Directed RNA Polymerases</subject><subject>Drug Resistance, Bacterial</subject><subject>Microbial Sensitivity Tests</subject><subject>Mutation</subject><subject>Mycobacterium tuberculosis</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Mycobacterium tuberculosis - genetics</subject><subject>Rifabutin - pharmacology</subject><subject>Rifampin - pharmacology</subject><issn>1476-0711</issn><issn>1476-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFkktv1DAURiMEoqWwZIssFuwCduI48QZRVTwqFbGBteXHTfEosad-jDS_p38UZ2ZUZkCIlZPc4-PP96aqXhL8lpCBvSO0ZzXuCalpzR9V5w_vj4-ez6pnMa4wbjBm_dPqjHS8Gwjrz6v7S32XbbTJeof8iIIdpcrJOhQg2pik04DUFsldZV5bfVRKaM67pWz8utVeSZ0g2DyjlBUEnSdfQGTdxk8biEg6lF2OWU4orkGnUMiydZEs5y-AQTDBRiYwaAxwl8Hp7fPqySinCC8O60X149PH71df6ptvn6-vLm9qRQfCaypB655TZZpBmZE3oMk4lOu3qmsNZ6zhXTfKZqRScZB9NzLGdQNqoLSjmLUX1fXea7xciXWwswxb4aUVuw8-3AoZktUTCGYarvoWaDmFGkOH1jCpmgYbkA3TXXG937vWWc1gNLgU5HQiPa04-1Pc-o0oQx1w1xTBh71AWf8PwWlF-1ksAxfLwAUVvCjeHDIEXzoZk5ht1DBN0oHPUbChxOf8_yDhtOelfQV8_Qe48jm4MpTCcIZ7ipfk9R7SwccYYHwITfByPfZXzFfHrfpNH37S9hdk4O1W</recordid><startdate>20050615</startdate><enddate>20050615</enddate><creator>Anthony, Richard M</creator><creator>Schuitema, Anja R J</creator><creator>Bergval, Indra L</creator><creator>Brown, Tim J</creator><creator>Oskam, Linda</creator><creator>Klatser, Paul R</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20050615</creationdate><title>Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency</title><author>Anthony, Richard M ; Schuitema, Anja R J ; Bergval, Indra L ; Brown, Tim J ; Oskam, Linda ; Klatser, Paul R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4819-4aecc794bd28bdf92ec1f80713b53d9662955fa2f4ab9ea75f669c2eb84454063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Bacterial Proteins - genetics</topic><topic>Codon</topic><topic>DNA-Directed RNA Polymerases</topic><topic>Drug Resistance, Bacterial</topic><topic>Microbial Sensitivity Tests</topic><topic>Mutation</topic><topic>Mycobacterium tuberculosis</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Mycobacterium tuberculosis - genetics</topic><topic>Rifabutin - pharmacology</topic><topic>Rifampin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anthony, Richard M</creatorcontrib><creatorcontrib>Schuitema, Anja R J</creatorcontrib><creatorcontrib>Bergval, Indra L</creatorcontrib><creatorcontrib>Brown, Tim J</creatorcontrib><creatorcontrib>Oskam, Linda</creatorcontrib><creatorcontrib>Klatser, Paul R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of clinical microbiology and antimicrobials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anthony, Richard M</au><au>Schuitema, Anja R J</au><au>Bergval, Indra L</au><au>Brown, Tim J</au><au>Oskam, Linda</au><au>Klatser, Paul R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency</atitle><jtitle>Annals of clinical microbiology and antimicrobials</jtitle><addtitle>Ann Clin Microbiol Antimicrob</addtitle><date>2005-06-15</date><risdate>2005</risdate><volume>4</volume><issue>1</issue><spage>9</spage><epage>9</epage><pages>9-9</pages><artnum>9</artnum><issn>1476-0711</issn><eissn>1476-0711</eissn><abstract>Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis. In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the rpoB gene were sequenced from 131 randomly selected mutants. Second round selection resulted in a changed frequency of specific mutations. Mycobacterium tuberculosis (strain Mtb72) rifamycin resistant mutants were selected in vitro with either rifampicin or rifabutin. One mutant R190 (rpoB S522L) selected with rifampicin had a rifampicin MIC of 32 microg/ml but remained sensitive to rifabutin (MIC&lt;0.8 microg/ml). This mutant was subjected to a second round of selection with rifabutin. All 105 first round resistant mutants derived from the parent strain (Mtb72) screened acquired mutations within the 81 bp rpoB hotspot. When the rifampicin resistant but rifabutin sensitive S522L mutant was subjected to a second round of selection, single additional rpoB mutations were identified in 24 (92%) of 26 second round mutants studied, but 14 (54%) of these strains contained mutations outside the 81 bp hotspot (codons 144, 146, 148, 505). Additionally, spontaneous rifabutin resistant mutants were produced at &gt;10 times the frequency by the S522L mutant than the parent strain. First round selection of mutation S522L with rifampicin increased the frequency and changed the spectrum of mutations identified after selection with rifabutin.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>15958167</pmid><doi>10.1186/1476-0711-4-9</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1476-0711
ispartof Annals of clinical microbiology and antimicrobials, 2005-06, Vol.4 (1), p.9-9, Article 9
issn 1476-0711
1476-0711
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6d29b73e492e4dd483d6ab220dea26c5
source PubMed Central(OpenAccess)
subjects Bacterial Proteins - genetics
Codon
DNA-Directed RNA Polymerases
Drug Resistance, Bacterial
Microbial Sensitivity Tests
Mutation
Mycobacterium tuberculosis
Mycobacterium tuberculosis - drug effects
Mycobacterium tuberculosis - genetics
Rifabutin - pharmacology
Rifampin - pharmacology
title Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acquisition%20of%20rifabutin%20resistance%20by%20a%20rifampicin%20resistant%20mutant%20of%20Mycobacterium%20tuberculosis%20involves%20an%20unusual%20spectrum%20of%20mutations%20and%20elevated%20frequency&rft.jtitle=Annals%20of%20clinical%20microbiology%20and%20antimicrobials&rft.au=Anthony,%20Richard%20M&rft.date=2005-06-15&rft.volume=4&rft.issue=1&rft.spage=9&rft.epage=9&rft.pages=9-9&rft.artnum=9&rft.issn=1476-0711&rft.eissn=1476-0711&rft_id=info:doi/10.1186/1476-0711-4-9&rft_dat=%3Cproquest_doaj_%3E19479629%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b4819-4aecc794bd28bdf92ec1f80713b53d9662955fa2f4ab9ea75f669c2eb84454063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199607402&rft_id=info:pmid/15958167&rfr_iscdi=true